Testicular, Spermatic Cord, and Scrotal Soft Tissue Sarcomas: Treatment Outcomes and Patterns of Failure

Table 1

Demographic information.

Total number of patients (N)	34
Median age at diagnosis (years)	42 (range, 5–81)
Median tumor size (cm)	6.25 (range, 0.8–14)
M stage at diagnosis
M0	26 (76.6)
M1	7 (20.6%)
Unknown	1 (2.9%)
Tumor site
Scrotal	11 (33.3%)
Spermatic cord	15 (45.5%)
Testis	8 (21.2%)
Histology
Well-differentiated liposarcoma	8 (23.5%)
Dedifferentiated liposarcoma	1 (2.9%)
Rhabdomyosarcoma	12 (35.3%)
Embryonal rhabdomyosarcoma	3 (25%)
Unknown type	9 (75%)
Leiomyosarcoma	9 (26.5%)
Myxoid liposarcoma	2 (5.9%)
Synovial sarcoma	2 (5.9%)
Method of diagnosis
Excisional biopsy/transcrotal surgery	14 (41.2%)
Inguinal orchiectomy	18 (52.9%)
Hernia repair	1 (2.9%)
Transcrotal surgery	7 (20.6%)
No biopsy, definitive surgery only	1 (2.9%)
Biopsy/nononcological resection prior to surgery
Yes	29 (85.3%)
No	4 (11.8%)
Unknown	1 (2.9%)